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Abstract: The diagnosis of American Tegumentary Leishmaniasis is a difficult but essential task when consider-
ing the high toxicity profile of the drugs available. Since the discovery of its etiologic agent, numerous diagnos-
tic tests have been developed. None of the tests available today can be considered as the gold standard, since they
do not add enough accuracy for the disease detection. Good epidemiological and clinical knowledge of the dis-
ease are fundamental precepts of the dermatology practice and precede the rational use of existing diagnostic
tests. In this article we aim, through extensive literature review, to recall fundamental concepts of any diagnos-
tic test. Subsequently, based on this information, we will weave important comments about the characteristics of
existing diagnostic tests, including immunological tests such as Montenegro's skin test, serology and detection of
parasites by direct examination, culture or histopathology. Finally we will discuss the new technologies and
options for the diagnosis of Cutaneous Leishmaniasis. The molecular biology technique is considered a promis-
ing tool, promoting the rapid identification of the species involved. We also aim to educate dermatologists about
a disease with high morbidity and assist in its difficult recognition.
Keywords: Dermatology: Diagnosis; Leishmaniasis, mucocutaneous; Molecular biology; Polymerase chain reac-
tion; Serologic tests
HISTORY
Historical documents refer to American
Tegumentary Leishmaniasis (ATL) in ancient times.
Archaeological studies of the pre-Columbian era
developed in Peru revealed mutilated human figures
in ceramics, currently accredited to ATL, but which
were for some years, confused with the clinical pres-
entation of syphilis.1 The description of cases of uncer-
tain etiology lasted until the early 20th century, before
the identification of the agents of the “Oriental but-
ton’’ by Wright in 1903, and the detection by
Lindemberg and Carini & Paranhos in 1909, of the
causative agent of epidemic ulcers, observed during
the railway construction in Northwest Bauru (São
Paulo - Brazil). This brief report demonstrates the dif-
ficulty experienced by great scientists in the character-
ization of ATL and its etiological agent.1
The year 2012 represented a milestone in the
history of leishmaniasis, celebrating the centennial of
the announcement of the discovery of treatment with
tartar emetic by Gaspar Vianna. This fact assumes
great importance if we consider that the current first-
line treatment of this disease still has relatively high
levels of toxicity.2,3 This report highlights the need for
an accurate diagnosis and also for advances in
research aimed at the early identification of the etio-
logic agent of ATL.
PRESENT SITUATION
The remarkable population and economic
growth in Brazil comes with new dilemmas concern-
ing public health, which need urgent solutions. The
uncontrolled expansion of urban boundaries is
accompanied by the appearance of numerous
pathologies, previously restricted to activities in areas
of native forest. Prompt diagnosis and treatment of
these diseases are crucial tasks, not always feasible,
due to their intrinsic complexity and frequent lack of
investment.
ATL is a mucocutaneous, infectious, parasitic
and vector-borne disease, caused by protozoa of the
genus Leishmania. Currently, it is considered a neglect-
ed disease. Epidemiological data point to an alarming
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increase in its incidence.4 This fact is due to the
increasing human contact with wild environments,
which are rich in parasitic reservoirs. Deforestation
and uncontrolled urbanization are the main causal
factors of this expansion.
The diagnosis of ATL is a difficult task. The tests
currently available do not add enough accuracy to be
considered the gold standard. For this reason, we use
a combination of epidemiological, clinical and labora-
tory data (immunological and parasitological exami-
nations) to reach the final diagnosis.4 Despite their
availability, more accurate tests require technical
training, not always existent in the most remote loca-
tions. Because of this limitation, in Brazil, many sus-
pected cases are still receiving treatment based solely
on clinical and epidemiological aspects. This is alarm-
ing, since the toxicity profile of existing drugs still
requires careful monitoring.5,6,7
The main diagnostic tests use the detection of
cellular or humoral immune responses to Leishmania
infection, plus the presence of the parasite itself or its
genetic material.8 Tests that detect the immune
response generally exhibit good sensitivity, but poor
specificity. The opposite happens with tests that aim
to visualize the parasite, which have high specificity
and low sensitivity. Molecular biology is a promising
tool for adding adequate sensitivity and specificity,
however its use is limited by the need of specialized
centers to execute the technique.
Diagnostic criteria for ATL have not been
homogeneously defined. Therefore, complementary
exams that help diagnose it are desirable, since this is
a disease in evident expansion.9 We will address
below the main strategies to diagnose ATL. 
EPIDEMIOLOGIC CRITERIA 
Obtaining epidemiological data is the first step
when there is a diagnostic suspicion of ATL. A history
of traveling to areas of native forest or other endemic
areas is considered relevant.10 The patient should be
asked about leisure activities, work and habitat.
The assessment of epidemiological criteria
becomes even more complicated when considering
the uncontrolled urban expansion that occurs in South
America, in view of the reports about urban transmis-
sion of ATL.11 For these reasons, if there is a compati-
ble dermatological presentation, the lack of history of
traveling to areas of native vegetation should not
exclude the diagnosis of ATL.
Judging by the epidemiology of the species
found, one can also try to infer a correlation between
the clinical form of leishmaniasis and the probable site
of infection. The species L. (V.) braziliensis and L. (L.)
amazonensis are present throughout the Brazilian terri-
tory in a proportion of 80% and 20% of cases, respec-
tively, while species such as L. (V.) guyanensis are more
restricted to the north part of the country.4,12,13
CLINICAL DIAGNOSIS 
The term ATL covers a wide clinical spectrum of
manifestations, according to several characteristics of
the host and the causative agent.4 Clinical examination,
despite not giving a definite diagnosis, is a useful tool
to every dermatologist, especially in defining which
diagnostic tests should be required. Considering
which area of skin is affected, ATL can be classified as
cutaneous, mucosal or mucocutaneous. Additional cri-
teria, such as medical history, time of evolution, distri-
bution, extent of lesions and host immunity,14,15 will be
addressed in the following classifications regarding
the utility of various diagnostic tests:
Localized Cutaneous Leishmaniasis 
The first sign of the localized cutaneous form is
the appearance of an erythematous spot at the site of
a mosquito bite, after an incubation period ranging
from 2 weeks to 3 months.9 This spot evolves into a
papule, that progressively ulcerates over a period of 2
weeks to 6 months (Figures 1 and 2).4 The typical
lesion is a round or oval painless ulcer, located on
exposed skin areas.16 Although the ulcerated form
comprises the vast majority of ATL cases, the disease

















ATL ulcer with elevated
borders: evolution of the
case after five months. 
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Exceptionally, other types of localized cuta-
neous lesions may be found. It is important to men-
tion the verrucous lesions that make differential diag-
nosis with deep mycoses and mycobacterioses, classi-
cally referred to by the acronym PLSCT (paracoccid-
ioidomycosis, leishmaniasis, sporotrichosis, chro-
momycosis and tuberculosis). Another important
example is the disease form that evolves with lym-
phangitis, combined or not with primary cutaneous
lesions, a presentation hardly differentiated from
sporotrichosis by clinical examination.
Leishmaniasis recidiva cutis is yet another mani-
festation of localized cutaneous leishmaniasis. It is char-
acterized by the appearance of papules, usually on the
periphery of an already healed ulcer. This form tends to
appear two years after the clinical cure of ATL following
poor treatment or lack thereof.18 The fact that it can be
considered a differentiated clinical form of ATL is contro-
versial, but such lesions as described above deserve spe-
cial attention, indicating a possible treatment resistance.
Disseminated Cutaneous Leishmaniasis 
It is a rare form of ATL characterized by the
appearance of at least 10 lesions, which may be papu-
lar, disseminated acneiform, ulcerated, with a high
incidence of mucosal involvement.19 It is believed that,
after the appearance of the primary lesion, an hemato-
genic or lymphatic dissemination occurs in patients
with relative cellular immunodeficiency against
Leishmania.20 This presentation may be accompanied
by systemic manifestations such as fever, malaise,
myalgia and weight loss.19
Diffuse Cutaneous Leishmaniasis 
The diffuse form of ATL occurs in patients with
impaired cellular immune response, necessary to fight
the infection. In Brazil, it is caused by L. (L.) amazonen-
sis.21 This clinical condition is characterized by nodular
or plaque lesions, rarely ulcerated, extensive and dif-
fuse.22 Affected patients present Montenegro skin test
(MST), in general, with negative or weak reactions.23
Mucosal Leishmaniasis 
The mucosal form tends to affect individuals
with improperly treated cutaneous form, preceded by
hematogenic dissemination of the parasite. Other fac-
tors may also be associated with mucosal involvement
such as the host’s immunity, male gender, extensive pri-
mary lesions or multiple lesions above the pelvic waist,
primary lesion persisting over a year and malnutrition.24
It is characterized by mucosal infiltration, which
may be associated to deformities and destruction of
facial structures, especially the nasal septum, and more
rarely the oral mucosa or oropharynx.4,25 (Figure 3) It
represents a form of ATL that is difficult to diagnose,
especially because of the challenge of obtaining biolog-
ical samples for laboratory tests. The mucosal form is
preferably due to L. (V.) braziliensis, although L. (L.)
amazonensis may, rarely, represent the causal agent.26
Unapparent infection 
The silent infection is considered as a simple
contact with the parasite or a Leishmania infection
without the development of apparent illness or the
characteristic scar. It should be suspected in individu-
als coming from endemic areas and it is based on pos-
itive serological tests and MST. There is no consensus
about the real meaning of this classification or on the
routinely adoption of immunological tests, since it is
not possible to predict its evolution towards clinical
disease, and also because of the large number of false
positive results obtained from these tests.27 Patients
with isolated positivity for the aforementioned
immunological tests should be carefully evaluated,
especially for the presence of mucosal lesions.
ATL associated to HIV infection 
ATL emerges as an opportunistic disease in
HIV-infected patients, being reported by some
authors as a possibly AIDS-defining illness.28 The cur-
rent trend towards ruralization of HIV infection, as
well as the concomitant urbanization of leishmaniasis
in Brazil, are important indicators of the increased
incidence of these cases. Co-infection of HIV /
Leishmania alters the clinical course of ATL, justified
by a heavy blow to the Th2 immune pole. This
increases the susceptibility of the host to infection and
is responsible for the development of anergic forms of
ATL.29 This situation is a problem for the public health
sector, since it is linked to greater diagnostic chal-
lenges, poorer prognosis and higher recurrence rates.
Cutaneous involvement in visceral
Leishmaniasis 
Although the description of the visceral form of
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skin lesions associated with kala-azar have been escalat-
ing.30 This form of the disease, also known as post-Kala-
azar cutaneous leishmaniasis, may appear clinically as
macules, papules or skin nodules arising after the cure
of visceral leishmaniasis.31 This association has been
described as a result of the spread of visceral leishmani-
asis in immunocompromised patients. It represents a
form that is hard to diagnose, so that tests that detect the
parasite or its genetic material, become essential. 
LABORATORY DIAGNOSIS 
CHARACTERISTICS OF A DIAGNOSTIC TEST 
Before starting detailed explanations on specif-
ic diagnostic strategies for ATL, it is important to note
the features inherent to any diagnostic test.32
- Sensitivity: Proportion of individuals in which
the diagnostic test will be positive, considering all
patients with the disease. It can also be seen, as the prob-
ability of a test being positive if the disease is present. It
measures the power of a test to diagnose the disease. In
the case of a test with high sensitivity, negative test results
are highly reliable, however, this characteristic does not
guarantee that all positive tests will be truly positive.
- Specificity: Proportion of individuals for
whom the diagnostic test will be negative, considering
all patients without the disease. It can also be seen, as
the probability of a test being negative in the absence
of the disease. A high specificity test does not guaran-
tee that all individuals with a particular disease will be
identified, but a positive result is usually reliable.
Sensitive tests are often used in cases of severe
illness, in which a false negative result would be very
harmful. It is also an appropriate test for rare diseases;
those in the early stages and also in situations where
one wants to perform a population screening.32
Specific tests are useful in diseases with high social
impact in which a false positive result can be very
detrimental, or those where the treatment may result
in substantial risk. It can also be used as a complemen-
tary test to confirm the diagnosis.32
- Positive predictive value: Refers to the propor-
tion of patients with true positive results among all pos-
itive results. It can be considered as the probability of the
disease being present in the case of a positive test result.
- Negative predictive value: Refers to the proportion
of patients with true negative results among all individuals
with negative tests. It can also be considered the probabili-
ty that the disease is absent if the test was negative.
- Accuracy: It measures the precision of a diagnostic
test, weighting and considering the values of sensitivity
and specificity. This estimates how much a test approach-
es the gold standard for the diagnosis of a disease.
Due to the absence of a gold standard test for
ATL diagnosis, it is important to mention some strate-
gies for combining diagnostic tests:
- Serial testing: Serial testing is generally used when
the test has little specificity if performed alone. In this case,
after the observation of a positive result, a new confirma-
tory test will be executed. This method aims to increase the
specificity and positive predictive value of a test.
- Parallel testing: this strategy is used in situa-
tions where a rapid diagnosis is necessary, despite the
higher cost to perform two tests simultaneously.
Parallel testing increases the sensitivity and negative
predictive values of the diagnostic process. Based on
these concepts we will address the features of the
main tests used in diagnosing ATL.
MONTENEGRO SKIN TEST
MST, also known as leishmanin skin test, eval-
uates the late cellular hypersensitivity response. The
test consists of an intradermal injection of a solution
containing an antigenic preparation of promastigotes
(Figure 4). It tends to show positive results within 3
months of infection, not having however frequent
positivity in acute infections and in anergic forms as
disseminated cutaneous leishmaniasis.
A result is considered positive with the appea-
rance of a hardened papule, equal or greater than
5mm after 48 hours of application on the anterior fore-
arm. It is a test of high sensitivity, low cost and mini-
mally invasive. According to studies, sensitivity can
reach over 90%.33,34 This positivity is directly propor-
tional to the length of disease evolution, so low values  
such as 30% reported in a few studies, can be
explained by the premature execution of the test,
when the cellular immune response is not yet com-
plete.33.34 Specificity varies around 75%.35 The relative-
ly low specificity can be explained by the overall large
number of false positive results in cases of unapparent
infection and cross-reactivity with some pathologies
such as Chagas disease, subcutaneous mycoses, tuber-
culosis and lepromatous leprosy, as well as technical
problems.36 The measurement is usually performed
using a ballpoint pen, starting from the normal skin
















is equal or greater
than 5mm
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posed the documentation of results drawn with ball-
point pen and the subsequent application of paper
soaked in alcohol.37 This method is expected to docu-
ment the test results more reliably and facilitate their
registration in the medical record. 
SEROLOGICAL TESTS
There are many serological tests for the diagno-
sis of cutaneous leishmaniasis. Among these we can
cite the indirect immunofluorescence assay (IFA), the
enzyme linked immunosorbent assay (ELISA) and
immunoblotting (Western blot) (Figure 5). The sensitiv-
ity and specificity of serologic tests shows great vari-
ability depending on the technique used and the pres-
entation of the disease. They tend to have negative
results within 3 months after the onset of the cutaneous
form of the disease. IFA and ELISA tests are considered
highly sensitive by most studies, reaching values
greater than 90%.34,38,39 Methodological flaws and pre-
mature execution of these exams, in the first moments
of infection, explain the few studies that attribute a low
positivity rate to them.34,38,39 Tests tend to be more sensi-
tive in infections caused by L. (V.) braziliensis compared
to diseases caused by L. (L.) amazonensis.38
Using Western blot for diagnosis of leishmaniasis
adds greater sensitivity to the process, sometimes reach-
ing close to 100%. However, it is a more costly exam that
requires greater technical laboratory infrastructure, thus
hindering its implementation as routine.39
As mentioned above, some authors consider
serological tests as having limited use for ATL diagno-
sis.39,40 However, their results may be considered as
diagnostic data to be added to physical examination
and other available tests. These are minimally inva-
sive exams that present, however, cross-reactions with
other diseases, such as Chagas disease, paracoccid-
ioidomycosis, pemphigus foliaceus, and deep
mycoses, thus explaining their low specificity. These
tests are widely used tools in epidemiological studies. 
Some authors recommend their use as a tool to
monitor cure, a complementary aid to physical exami-
nation, considering that after treatment their values are
expected to remain stable or even decrease.41 On the
other hand, the increase of values should warn to the
possibility of relapse, a fact to be appraised in conjunc-
tion with clinical evaluation, the latter still considered
the main form of relapse assessment in this disease. 
DIRECT EXAM
The execution of direct exam has several techni-
cal variations. To collect the material, some strategies
may be used, such as scrapping by scalpel or brush,
needle aspiration, imprint of excised fragments on
slides and washing of oral or nasal mucosa.42,43 Stains
like Wright, Giemsa and Papanicolau can be used.
It has the advantage of being a low-cost test that
when positive may give a definite diagnosis, present-
ing as a useful tool for the early initiation of treatment.
It has a variable sensitivity, from 15-70% depending
on how old the lesion is, and it is considered relative-
ly low, especially in lesions with more than 3 months
of evolution, and in chronic hyperergic forms of
ATL.34,35,38 Although this method depends on the expe-
rience of the examiner, it has an almost complete
specificity, since the finding of amastigotes virtually
confirms the diagnosis.35 Few data concerning the
influence of various types of collection are available. A
recent study showed greater sensitivity for needle
aspirate cytology (89%) compared to scaling by
scalpel (80%) with statistically significant results. The
specificity of the two methods remained similar.43
HISTOPATHOLOGICAL EXAM
Histopathological exam is an everyday tool in
dermatology. The biopsy should be performed prefer-
entially on the active border of the lesion and not in its
center.44 Higher sensitivity of diagnosis can be achieved
with the use of immunohistochemistry or immunocy-
tochemistry.9,45 Visualization of amastigote forms is not
usually easy, specially in chronic lesions.42,46
This method is less successful in visualizing, in
great detail, the amastigote forms that can furthermore
be mistaken for fungal elements of histoplasmosis or
parasites of toxoplasmosis, as well as artifacts, explain-
ing the low specificity of the test.42 (Figure 6) The clas-
sic histopathological findings consist in a non-specific
granulomatous reaction, with an inflammatory infil-
trate rich in plasma cells and lymphocytes. An exuber-
ant pseudoepitheliomatous hyperplasia may occur,
which leads to a differential diagnosis with squamous
cell carcinoma (Figure 7).47 Particularly in mucosal
leishmaniasis, the amastigote forms are very scarse.42
FIGURE 5: Indirect search for antibodies. Positive result with fluores-
cence of the promastigote forms of Leishmania
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CULTURE
Several technical variations are described for
carrying out cultures in ATL diagnosis. This proce-
dure may be realized in vitro by microculture or tradi-
tional culture, as well as in vivo. Some of the tradition-
al techniques for in vitro culture consist in seeding the
material in Neal, Novy, Nicolle (NNN) solid phase or
in a liquid medium such as Schneider’s. (Figure 8)
Traditional culture’s sensitivity may vary between 40
to 75% and it has a nearly complete specificity, since
the visualization of the seeded promastigote form is
typical.35,44 Needle aspiration on the border of the
lesion may provide material to be seeded in the afore-
mentioned media.48,49
New microculture techniques that have been
developed, demonstrate a higher diagnostic accuracy
than that of traditional culture, besides needing a
shorter incubation period to achieve its conclusion (an
average of 2 days).50,51 It appears to be a less costly
method than the traditional one, since it utilizes only
a small quantity of the culture medium.52 It has, how-
ever, the disadvantage of producing only a small
quantity of promastigote forms, which may hinder the
execution of new experiments.35
In vivo culture requires a complex methodology,
carrying risks of accidents by inoculation and
demanding an experienced technician for its execu-
tion (Figure 9). This method is subject to ethical
impediments and it is not commonly used in diagnos-
tic routines. It is noteworthy that this is an important
complementary tool, especially in dubious cases and
during researches. 
MOLECULAR BIOLOGY
The use of molecular biology in the diagnosis of
leishmaniasis is considered a promising notion,
because it allies at the same time, higher sensitivity
and specificity in comparison to other tests
described.53 It must be highlighted, however, that this
test is not available in most reference centers. 
Several types of sample may be used in order to
extract genetic material to be analyzed by molecular biol-
ogy tests. Among others are the fragments obtained from
incisional biopsy either fresh, frozen or paraffin embed-
ded; in addition to samples obtained from non-invasive
procedures such as scarification of the lesion. Other men-
tioned techniques, as lesion imprint on filter paper have
the advantage of an easy storage until the moment of
DNA extraction and execution of the test (Figure 10).54,55,56
After the collection, the DNA can be extracted from cells
through several laboratorial techniques, including by the
use of commercially available kits. 
After the extraction process, all DNA present in
the sample is purified, ideally free of proteins and
contaminant reagents. The amount of DNA is still
undetectable, and in order to identify remains of the
parasite it is necessary that this DNA be amplified.54
In vitro DNA amplification is obtained through
Polymerase Chain Reaction (PCR) technique, which
consists in replicating small amounts of DNA (or









h m a n i a s i s
(Giemsa 400x)
FIGURE 9: In vivo culture:  C57BL/6 strain mouse, Mus musculus spe-
cies, adult female infected subcutaneously on the right paw with





s h o w i n g
intense pseu-
doepithelio-
m a t o u s
hyperplasia
(H&E 10x)
FIGURE 8: Solid culture medium for
Leishmania - Neal, Novy, Nicolle
(NNN). The sample material aspirated
from the border of the cutaneous ulcer
can be inoculated in this medium
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FIGURE 10: 
Collection technique of
an imprint in paper filter
of material from incisio-
nal biopsy. The collected
material can be easily sto-
red, sent for DNA extrac-
tion and polymerase
chain reaction 
FIGURE 11: Agarose gel print of PCR amplified material showing
positivity for Leishmania spp. Sample collected from a lesion, in a
case of mucosal leishmaniasis, by paper filter imprinting (6) and
nasal swab (7). Demonstration of positivity on incisional biopsy
sample, in a case of cutaneous leishmaniasis (9). Positive control
(10). Negative control (11). 100 bp molecular marker (12). Exam per-
formed at the Dermatology Service Laboratory, HC-FMRP-USP,
Ribeirão Preto, SP, Brazil
ature changes, simulating the physiological replica-
tion of DNA. This process consists of three phases
described below:54,57
1. The extracted double-stranded DNA is separat-
ed in two simple strands, at 92 to 96 degrees Celsius,
a process known as thermal denaturation. The single
strands will be templates for the chain amplification
of new strands. 
2. The presence of oligonucleotides, known as
primers or initiators, that bond to a specific target
region of the template DNA at a temperature of 58 to
65 degrees Celsius is necessary to allow the amplifica-
tion to begin in the template strand. This connection
will be the primer for chain amplification. 
3. Through a polymerase enzyme, new nucleotides
are added to extend the primer sequence until the sin-
gle strands are complemented, thus duplicating the
initial DNA sample. 
These three steps are repeated several times,
and at each additional cycle, the freshly replicated
molecules also become templates for new amplifica-
tions, multiplying exponentially the amount of DNA.
These characteristics are responsible for the high sen-
sitivity of this method, even if the initial amount of
DNA extracted from the collected sample is small. 
The last step consists in the analysis of the
amplified product and its comparison to previously
established controls. At the end of the PCR process,
the target DNA is multiplied and to visualize this
result it is necessary to perform an agarose or poly-
acrylamide gel electrophoresis (Figures 11 and 12). 
This method has a variable detection rate,
depending on the collection technique, extraction,
purification and amplification of targeted DNA.
Sensitivity may vary around 60%, but it tends to reach
higher values, often close to 100%.58,59
FIGURE 12: 10% acrylamide gel electrophoresis after enzymatic
digestion of PCR amplified material - PCR-RFLP. Digestion by the
enzyme HaeIII in species L. donovani (4); L. (V.) braziliensis (5); L (L.)
amazonensis (6) kept in culture. Digestion by the enzyme BsrI in spe-
cies L. donovani (12); L. (V.) braziliensis (13); L (L.) amazonensis (14)
kept in culture. Depicts 50 bp and 100bp molecular markers respec-
tively (7, 8). Exam performed at the Dermatology Service
Laboratory, HC-FMRP-USP, Ribeirão Preto, SP, Brazil
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SPECIES IDENTIFICATION
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CONCLUSION
ATL diagnosis is a difficult yet essential task,
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